COVID-19 ARDS: A Multispecialty Assessment of Challenges in Care, Review of Research, and Recommendations
- PMID: 34349364
- PMCID: PMC8289635
- DOI: 10.4103/joacp.JOACP_14_21
COVID-19 ARDS: A Multispecialty Assessment of Challenges in Care, Review of Research, and Recommendations
Abstract
Physicians and care providers are familiar with the management of ARDS, however, when it occurs as a sequalae of COVID-19, it has different features and there remains uncertainty on the consensus of management. To answer this question on how it compares and contrasts with ARDS from other causes, the authors reviewed the published literature and management guidelines as well as their own clinical experience while managing patients with COVID-19 ARDS. For research, a PubMed search was conducted on 01.04.2021 using the systematic review filter to identify articles that were published using MeSH terms COVID-19 and ARDS. Systematic reviews or meta-analyses were selected from a systematic search for literature containing diagnostic, prognostic and management strategies in MEDLINE/PubMed. Those were compared and reviewed to the existing practices by the various treating specialists and recommendations were made. Specifically, the COVID-19 ARDS, its risk factors and pathophysiology, lab diagnosis, radiological findings, rational of recommendation of drugs proposed so far, oxygenation and ventilation strategies and the psychological ramifications of the disease were. discussed. Because of the high mortality in mechanically ventilated patients, the above recommendations and findings direct the potential for improvement in the management of patients with COVID-19 ARDS.
Keywords: ARDS; COVID19; ICU.
Copyright: © 2021 Journal of Anaesthesiology Clinical Pharmacology.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- World Health Organization. GCM teleconference – Note for the Records. 10 January 2020. Subject: Pneumonia in Wuhan, China. [Last accessed on 2020 Jul 09]. Available from: https://www.who.int/blueprint/10-01-2020-nfr-gcm.pdf .
-
- Xie P, Ma W, Tang H, Liu D. Front Public Health. Vol. 8. World Health Organization; 2020. Severe COVID-19: A review of recent progress with a look toward the future; p. 189. Teleconference of the R and D Blueprint GCM. 20 January 2020. Pneumonia of unknown etiology in Wuhan China. Available from: https://www.who.int/blueprint/priority-diseases/key-action/20-01-2020-nf... . - PMC - PubMed
-
- World Health Organization. Novel coronavirus (2019-nCoV). Situation Report – 1. 21 January 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situationreports/20... .
-
- “WHO Coronavirus Disease (COVID-19) Dashboard.”. World Health Organization, World Health Organization;
-
- Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Napoli RD. Features, Evaluation and Treatment Coronavirus (COVID-19) StatPearls Publishing; 2020. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous